Quotes 5-day view Delayed Nyse
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
110.84(c)
108.84(c)
112.15(c)
110.04(c)
111.3(c)
Last
3 177 736
5 777 386
6 047 106
4 391 349
4 459 430
Volume
-0.69%
-1.80%
+3.04%
-1.88%
+1.15%
Change
Sales 2020
33 853 M
-
-
Net income 2020
4 415 M
-
-
Net Debt 2020
11 794 M
-
-
P/E ratio 2020
45,4x
Yield 2020
1,29%
Sales 2021
38 321 M
-
-
Net income 2021
5 807 M
-
-
Net Debt 2021
8 819 M
-
-
P/E ratio 2021
35,1x
Yield 2021
1,41%
Capitalization
191 B
191 B
-
EV / Sales 2020
5,98x
EV / Sales 2021
5,21x
Nbr of Employees
107 000
Free-Float
88,9%
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products,...
Notations Surperformance© of Abbott Laboratories
Trading Rating :
Investor Rating :
All news about ABBOTT LABORATORIES
News in other languages on ABBOTT LABORATORIES
2020 Des sorcières, des dragons et des pirates
2020 AVIS D'ANALYSTES DU JOUR : ABB, Delta Plus, EDP, Galapagos, HelloFresh, Sika, Ve..
2020 CORONAVIRUS : Mepha distribue en Suisse le test rapide d'Abbott
2020 Generikafirma Mepha holt weiteren Covid-19-Schnelltest in die Schweiz
2020 AVIS D'ANALYSTES DU JOUR : Adidas, Chargeurs, Daimler, EDF, Ipsen, L'Oréal, SAP,..
Analyst Recommendations on ABBOTT LABORATORIES
United to give travelers free COVID-19 tests on select Newark-London flights
Chart ABBOTT LABORATORIES
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ABBOTT LABORATORIES
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
23
Average target price
120,22 $
Last Close Price
111,30 $
Spread / Highest target
21,3%
Spread / Average Target
8,02%
Spread / Lowest Target
-26,3%
Please enable JavaScript in your browser's settings to use dynamic charts.